Global Molecular Imaging Device research

Molecular Imaging Device Comprehensive Study by Type (Nuclear Medicine, PET/CT, PET Radiopharmacy, Other), Application (Oncology, Cardio and vascular, Neurology, Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)), Imaging technologies (Gamma camera, Single-photon emission computed tomography (SPECT), Molecular ultrasound imaging, Others), End users (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers (ASCs)), Molecular imaging agents (Small molecules, Peptides, Engineered protein fragments, Aptamers, Nanoparticles, Others) Players and Region - Global Market Outlook to 2030

Molecular Imaging Device Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Imaging Device
Molecular Imaging is a type of technique used by the devices so that they can provide better quality pictures or can ensure the full digital representation of internal organs in a body. Physicians use these devices to diagnose the diseases associated with the human body. Moreover, it also offers a unique insight into the human body allows the physicians to personalize patient care in terms of diagnosis. Molecular imaging devices ensures in delivering different information coupled with the potential disease in a body. Furthermore, it also provides information which is unattainable by other imaging technologies. Hence it is Important to have these molecular imaging devices. According to United States Department of Health and Human Services, there has been a significant rise in a number of cancer death rates with figure stood up to ~512,000 in the United States alone in 2015, for control & dropping death rates, it's required to implement imaging device. So, the future for molecular imaging device looks promising.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia- Pacific
UnitValue (USD Million)
CAGR9.3%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through new development, expansions and acquisitions across the globe to avail competitive advantage through combined collaborations.The Players having a strong hold in the market are Siemens AG and Hitachi Medical Corporation. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Molecular Imaging Device market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

GE Healthcare (United States), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), PerkinElmer (United States), Cyclopharma (France), Hamamatsu Photonics (Japan), Scintomics (Germany), CardiArc Ltd. (United States), Digirad Corporation (United States) and Gamma Medica (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Gvi Medical Devices (United States), Hitachi (Japan), Mediso (Europe), CMR Naviscan (United States), NeuroLogica Corp (United States), Toshiba (Japan) and Molecular Devices (United States).

Segmentation Overview
AMA Research has segmented the market of Global Molecular Imaging Device market by Type (Nuclear Medicine, PET/CT, PET Radiopharmacy and Other), Application (Oncology, Cardio and vascular, Neurology and Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)) and Region.



On the basis of geography, the market of Molecular Imaging Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. If we see Market by Imaging technologies, the sub-segment i.e. Gamma camera will boost the Molecular Imaging Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End users, the sub-segment i.e. Hospitals will boost the Molecular Imaging Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Molecular imaging agents, the sub-segment i.e. Small molecules will boost the Molecular Imaging Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Adoption of Personalize Patient Care through these Devices, Mounting Consistent Innovation in Technology and Growing Availability of these Devices and Growing Adoption of Hybrid Molecular Imaging Systems

Market Growth Drivers:
Rising Incidence of Chronic Diseases Resulting in Increased Demand for Diagnostic Equipment and Rapidly Growing Geriatric Population with Weaker Immune System

Challenges:
Issue Related Towards Product Recalls and Safety Concerns towards these Devices and Low Availability of Health Insurance Provider and Limited Government Support Policies in Developing Nations

Restraints:
Insufficient Supply of Molecular Isotopes in North America Region is Hampering the Market and High Cost of these Molecular Imaging Devices

Opportunities:
Growing Technological Advancements in the Medical Sector Such as Non-Ionizing Bio-Imaging Techniques, Including CT and MRI, Scans in Hospitals and Rising Demand for Highly Accurate and Most Efficient Imaging Devices

Market Leaders and their expansionary development strategies
May 2020, Konica Minolta, Inc. (Konica Minolta) has entered into an agreement on the joint development of artificial intelligence (AI) with Enlitic, Inc. (Enlitic), a pioneering startup company which specializes in developing AI for medical image analysis.
On 14TH May 2023, United Imaging Healthcare (UIH) presented its full portfolio of diagnosis, radiotherapy equipment, AI and digital medical products and solutions at the China International Medical Equipment Fair (CMEF) 2019. They presented this product through a theme “Desire to create”. UNI presented a total of 8 cutting-edge new products, together with the latest trail-blazing researches on molecular imaging.


Key Target Audience
Molecular Imaging Device Manufacturers, Healthcare Industry, Potential Investors, Industry Associations, Marketing & Consulting Firms, Government & Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Nuclear Medicine
  • PET/CT
  • PET Radiopharmacy
  • Other
By Application
  • Oncology
  • Cardio and vascular
  • Neurology
  • Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)
By Imaging technologies
  • Gamma camera
  • Single-photon emission computed tomography (SPECT)
  • Molecular ultrasound imaging
  • Others

By End users
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers (ASCs)

By Molecular imaging agents
  • Small molecules
  • Peptides
  • Engineered protein fragments
  • Aptamers
  • Nanoparticles
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence of Chronic Diseases Resulting in Increased Demand for Diagnostic Equipment
      • 3.2.2. Rapidly Growing Geriatric Population with Weaker Immune System
    • 3.3. Market Challenges
      • 3.3.1. Issue Related Towards Product Recalls and Safety Concerns towards these Devices
      • 3.3.2. Low Availability of Health Insurance Provider and Limited Government Support Policies in Developing Nations
    • 3.4. Market Trends
      • 3.4.1. Adoption of Personalize Patient Care through these Devices
      • 3.4.2. Mounting Consistent Innovation in Technology and Growing Availability of these Devices
      • 3.4.3. Growing Adoption of Hybrid Molecular Imaging Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Imaging Device, by Type, Application, Imaging technologies, End users, Molecular imaging agents and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Imaging Device (Value)
      • 5.2.1. Global Molecular Imaging Device by: Type (Value)
        • 5.2.1.1. Nuclear Medicine
        • 5.2.1.2. PET/CT
        • 5.2.1.3. PET Radiopharmacy
        • 5.2.1.4. Other
      • 5.2.2. Global Molecular Imaging Device by: Application (Value)
        • 5.2.2.1. Oncology
        • 5.2.2.2. Cardio and vascular
        • 5.2.2.3. Neurology
        • 5.2.2.4. Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)
      • 5.2.3. Global Molecular Imaging Device by: Imaging technologies (Value)
        • 5.2.3.1. Gamma camera
        • 5.2.3.2. Single-photon emission computed tomography (SPECT)
        • 5.2.3.3. Molecular ultrasound imaging
        • 5.2.3.4. Others
      • 5.2.4. Global Molecular Imaging Device by: Molecular imaging agents (Value)
        • 5.2.4.1. Small molecules
        • 5.2.4.2. Peptides
        • 5.2.4.3. Engineered protein fragments
        • 5.2.4.4. Aptamers
        • 5.2.4.5. Nanoparticles
        • 5.2.4.6. Others
      • 5.2.5. Global Molecular Imaging Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Molecular Imaging Device (Volume)
      • 5.3.1. Global Molecular Imaging Device by: Type (Volume)
        • 5.3.1.1. Nuclear Medicine
        • 5.3.1.2. PET/CT
        • 5.3.1.3. PET Radiopharmacy
        • 5.3.1.4. Other
      • 5.3.2. Global Molecular Imaging Device by: Application (Volume)
        • 5.3.2.1. Oncology
        • 5.3.2.2. Cardio and vascular
        • 5.3.2.3. Neurology
        • 5.3.2.4. Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)
      • 5.3.3. Global Molecular Imaging Device by: Imaging technologies (Volume)
        • 5.3.3.1. Gamma camera
        • 5.3.3.2. Single-photon emission computed tomography (SPECT)
        • 5.3.3.3. Molecular ultrasound imaging
        • 5.3.3.4. Others
      • 5.3.4. Global Molecular Imaging Device by: Molecular imaging agents (Volume)
        • 5.3.4.1. Small molecules
        • 5.3.4.2. Peptides
        • 5.3.4.3. Engineered protein fragments
        • 5.3.4.4. Aptamers
        • 5.3.4.5. Nanoparticles
        • 5.3.4.6. Others
      • 5.3.5. Global Molecular Imaging Device Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Molecular Imaging Device (Price)
      • 5.4.1. Global Molecular Imaging Device by: Type (Price)
  • 6. Molecular Imaging Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GE Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens Healthcare (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Philips Healthcare (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cyclopharma (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hamamatsu Photonics (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Scintomics (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CardiArc Ltd. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Digirad Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Gamma Medica (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Molecular Imaging Device Sale, by Type, Application, Imaging technologies, End users, Molecular imaging agents and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Imaging Device (Value)
      • 7.2.1. Global Molecular Imaging Device by: Type (Value)
        • 7.2.1.1. Nuclear Medicine
        • 7.2.1.2. PET/CT
        • 7.2.1.3. PET Radiopharmacy
        • 7.2.1.4. Other
      • 7.2.2. Global Molecular Imaging Device by: Application (Value)
        • 7.2.2.1. Oncology
        • 7.2.2.2. Cardio and vascular
        • 7.2.2.3. Neurology
        • 7.2.2.4. Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)
      • 7.2.3. Global Molecular Imaging Device by: Imaging technologies (Value)
        • 7.2.3.1. Gamma camera
        • 7.2.3.2. Single-photon emission computed tomography (SPECT)
        • 7.2.3.3. Molecular ultrasound imaging
        • 7.2.3.4. Others
      • 7.2.4. Global Molecular Imaging Device by: Molecular imaging agents (Value)
        • 7.2.4.1. Small molecules
        • 7.2.4.2. Peptides
        • 7.2.4.3. Engineered protein fragments
        • 7.2.4.4. Aptamers
        • 7.2.4.5. Nanoparticles
        • 7.2.4.6. Others
      • 7.2.5. Global Molecular Imaging Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Molecular Imaging Device (Volume)
      • 7.3.1. Global Molecular Imaging Device by: Type (Volume)
        • 7.3.1.1. Nuclear Medicine
        • 7.3.1.2. PET/CT
        • 7.3.1.3. PET Radiopharmacy
        • 7.3.1.4. Other
      • 7.3.2. Global Molecular Imaging Device by: Application (Volume)
        • 7.3.2.1. Oncology
        • 7.3.2.2. Cardio and vascular
        • 7.3.2.3. Neurology
        • 7.3.2.4. Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging)
      • 7.3.3. Global Molecular Imaging Device by: Imaging technologies (Volume)
        • 7.3.3.1. Gamma camera
        • 7.3.3.2. Single-photon emission computed tomography (SPECT)
        • 7.3.3.3. Molecular ultrasound imaging
        • 7.3.3.4. Others
      • 7.3.4. Global Molecular Imaging Device by: Molecular imaging agents (Volume)
        • 7.3.4.1. Small molecules
        • 7.3.4.2. Peptides
        • 7.3.4.3. Engineered protein fragments
        • 7.3.4.4. Aptamers
        • 7.3.4.5. Nanoparticles
        • 7.3.4.6. Others
      • 7.3.5. Global Molecular Imaging Device Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Molecular Imaging Device (Price)
      • 7.4.1. Global Molecular Imaging Device by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Imaging Device: by Type(USD Million)
  • Table 2. Molecular Imaging Device Nuclear Medicine , by Region USD Million (2018-2023)
  • Table 3. Molecular Imaging Device PET/CT , by Region USD Million (2018-2023)
  • Table 4. Molecular Imaging Device PET Radiopharmacy , by Region USD Million (2018-2023)
  • Table 5. Molecular Imaging Device Other , by Region USD Million (2018-2023)
  • Table 6. Molecular Imaging Device: by Application(USD Million)
  • Table 7. Molecular Imaging Device Oncology , by Region USD Million (2018-2023)
  • Table 8. Molecular Imaging Device Cardio and vascular , by Region USD Million (2018-2023)
  • Table 9. Molecular Imaging Device Neurology , by Region USD Million (2018-2023)
  • Table 10. Molecular Imaging Device Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging) , by Region USD Million (2018-2023)
  • Table 11. Molecular Imaging Device: by Imaging technologies(USD Million)
  • Table 12. Molecular Imaging Device Gamma camera , by Region USD Million (2018-2023)
  • Table 13. Molecular Imaging Device Single-photon emission computed tomography (SPECT) , by Region USD Million (2018-2023)
  • Table 14. Molecular Imaging Device Molecular ultrasound imaging , by Region USD Million (2018-2023)
  • Table 15. Molecular Imaging Device Others , by Region USD Million (2018-2023)
  • Table 16. Molecular Imaging Device: by Molecular imaging agents(USD Million)
  • Table 17. Molecular Imaging Device Small molecules , by Region USD Million (2018-2023)
  • Table 18. Molecular Imaging Device Peptides , by Region USD Million (2018-2023)
  • Table 19. Molecular Imaging Device Engineered protein fragments , by Region USD Million (2018-2023)
  • Table 20. Molecular Imaging Device Aptamers , by Region USD Million (2018-2023)
  • Table 21. Molecular Imaging Device Nanoparticles , by Region USD Million (2018-2023)
  • Table 22. Molecular Imaging Device Others , by Region USD Million (2018-2023)
  • Table 23. South America Molecular Imaging Device, by Country USD Million (2018-2023)
  • Table 24. South America Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 25. South America Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 26. South America Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 27. South America Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 28. South America Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 29. Brazil Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 30. Brazil Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 31. Brazil Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 32. Brazil Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 33. Brazil Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 34. Argentina Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 35. Argentina Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 36. Argentina Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 37. Argentina Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 38. Argentina Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 39. Rest of South America Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 40. Rest of South America Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 41. Rest of South America Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 42. Rest of South America Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 43. Rest of South America Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 44. Asia Pacific Molecular Imaging Device, by Country USD Million (2018-2023)
  • Table 45. Asia Pacific Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 46. Asia Pacific Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 47. Asia Pacific Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 48. Asia Pacific Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 49. Asia Pacific Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 50. China Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 51. China Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 52. China Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 53. China Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 54. China Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 55. Japan Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 56. Japan Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 57. Japan Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 58. Japan Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 59. Japan Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 60. India Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 61. India Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 62. India Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 63. India Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 64. India Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 65. South Korea Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 66. South Korea Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 67. South Korea Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 68. South Korea Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 69. South Korea Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 70. Taiwan Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 71. Taiwan Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 72. Taiwan Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 73. Taiwan Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 74. Taiwan Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 75. Australia Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 76. Australia Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 77. Australia Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 78. Australia Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 79. Australia Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 80. Rest of Asia-Pacific Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 81. Rest of Asia-Pacific Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 85. Europe Molecular Imaging Device, by Country USD Million (2018-2023)
  • Table 86. Europe Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 87. Europe Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 88. Europe Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 89. Europe Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 90. Europe Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 91. Germany Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 92. Germany Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 93. Germany Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 94. Germany Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 95. Germany Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 96. France Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 97. France Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 98. France Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 99. France Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 100. France Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 101. Italy Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 102. Italy Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 103. Italy Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 104. Italy Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 105. Italy Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 106. United Kingdom Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 107. United Kingdom Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 108. United Kingdom Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 109. United Kingdom Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 110. United Kingdom Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 111. Netherlands Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 112. Netherlands Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 113. Netherlands Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 114. Netherlands Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 115. Netherlands Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 116. Rest of Europe Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 117. Rest of Europe Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 118. Rest of Europe Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 119. Rest of Europe Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 120. Rest of Europe Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 121. MEA Molecular Imaging Device, by Country USD Million (2018-2023)
  • Table 122. MEA Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 123. MEA Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 124. MEA Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 125. MEA Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 126. MEA Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 127. Middle East Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 128. Middle East Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 129. Middle East Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 130. Middle East Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 131. Middle East Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 132. Africa Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 133. Africa Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 134. Africa Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 135. Africa Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 136. Africa Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 137. North America Molecular Imaging Device, by Country USD Million (2018-2023)
  • Table 138. North America Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 139. North America Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 140. North America Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 141. North America Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 142. North America Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 143. United States Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 144. United States Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 145. United States Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 146. United States Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 147. United States Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 148. Canada Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 149. Canada Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 150. Canada Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 151. Canada Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 152. Canada Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 153. Mexico Molecular Imaging Device, by Type USD Million (2018-2023)
  • Table 154. Mexico Molecular Imaging Device, by Application USD Million (2018-2023)
  • Table 155. Mexico Molecular Imaging Device, by Imaging technologies USD Million (2018-2023)
  • Table 156. Mexico Molecular Imaging Device, by End users USD Million (2018-2023)
  • Table 157. Mexico Molecular Imaging Device, by Molecular imaging agents USD Million (2018-2023)
  • Table 158. Molecular Imaging Device Sales: by Type(K units)
  • Table 159. Molecular Imaging Device Sales Nuclear Medicine , by Region K units (2018-2023)
  • Table 160. Molecular Imaging Device Sales PET/CT , by Region K units (2018-2023)
  • Table 161. Molecular Imaging Device Sales PET Radiopharmacy , by Region K units (2018-2023)
  • Table 162. Molecular Imaging Device Sales Other , by Region K units (2018-2023)
  • Table 163. Molecular Imaging Device Sales: by Application(K units)
  • Table 164. Molecular Imaging Device Sales Oncology , by Region K units (2018-2023)
  • Table 165. Molecular Imaging Device Sales Cardio and vascular , by Region K units (2018-2023)
  • Table 166. Molecular Imaging Device Sales Neurology , by Region K units (2018-2023)
  • Table 167. Molecular Imaging Device Sales Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging) , by Region K units (2018-2023)
  • Table 168. Molecular Imaging Device Sales: by Imaging technologies(K units)
  • Table 169. Molecular Imaging Device Sales Gamma camera , by Region K units (2018-2023)
  • Table 170. Molecular Imaging Device Sales Single-photon emission computed tomography (SPECT) , by Region K units (2018-2023)
  • Table 171. Molecular Imaging Device Sales Molecular ultrasound imaging , by Region K units (2018-2023)
  • Table 172. Molecular Imaging Device Sales Others , by Region K units (2018-2023)
  • Table 173. Molecular Imaging Device Sales: by Molecular imaging agents(K units)
  • Table 174. Molecular Imaging Device Sales Small molecules , by Region K units (2018-2023)
  • Table 175. Molecular Imaging Device Sales Peptides , by Region K units (2018-2023)
  • Table 176. Molecular Imaging Device Sales Engineered protein fragments , by Region K units (2018-2023)
  • Table 177. Molecular Imaging Device Sales Aptamers , by Region K units (2018-2023)
  • Table 178. Molecular Imaging Device Sales Nanoparticles , by Region K units (2018-2023)
  • Table 179. Molecular Imaging Device Sales Others , by Region K units (2018-2023)
  • Table 180. South America Molecular Imaging Device Sales, by Country K units (2018-2023)
  • Table 181. South America Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 182. South America Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 183. South America Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 184. South America Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 185. South America Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 186. Brazil Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 187. Brazil Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 188. Brazil Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 189. Brazil Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 190. Brazil Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 191. Argentina Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 192. Argentina Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 193. Argentina Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 194. Argentina Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 195. Argentina Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 196. Rest of South America Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 197. Rest of South America Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 198. Rest of South America Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 199. Rest of South America Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 200. Rest of South America Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 201. Asia Pacific Molecular Imaging Device Sales, by Country K units (2018-2023)
  • Table 202. Asia Pacific Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 203. Asia Pacific Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 204. Asia Pacific Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 205. Asia Pacific Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 206. Asia Pacific Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 207. China Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 208. China Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 209. China Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 210. China Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 211. China Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 212. Japan Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 213. Japan Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 214. Japan Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 215. Japan Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 216. Japan Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 217. India Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 218. India Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 219. India Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 220. India Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 221. India Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 222. South Korea Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 223. South Korea Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 224. South Korea Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 225. South Korea Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 226. South Korea Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 227. Taiwan Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 228. Taiwan Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 229. Taiwan Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 230. Taiwan Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 231. Taiwan Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 232. Australia Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 233. Australia Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 234. Australia Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 235. Australia Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 236. Australia Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 237. Rest of Asia-Pacific Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 238. Rest of Asia-Pacific Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 239. Rest of Asia-Pacific Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 240. Rest of Asia-Pacific Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 241. Rest of Asia-Pacific Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 242. Europe Molecular Imaging Device Sales, by Country K units (2018-2023)
  • Table 243. Europe Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 244. Europe Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 245. Europe Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 246. Europe Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 247. Europe Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 248. Germany Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 249. Germany Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 250. Germany Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 251. Germany Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 252. Germany Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 253. France Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 254. France Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 255. France Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 256. France Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 257. France Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 258. Italy Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 259. Italy Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 260. Italy Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 261. Italy Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 262. Italy Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 263. United Kingdom Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 264. United Kingdom Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 265. United Kingdom Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 266. United Kingdom Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 267. United Kingdom Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 268. Netherlands Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 269. Netherlands Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 270. Netherlands Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 271. Netherlands Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 272. Netherlands Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 273. Rest of Europe Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 274. Rest of Europe Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 275. Rest of Europe Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 276. Rest of Europe Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 277. Rest of Europe Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 278. MEA Molecular Imaging Device Sales, by Country K units (2018-2023)
  • Table 279. MEA Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 280. MEA Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 281. MEA Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 282. MEA Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 283. MEA Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 284. Middle East Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 285. Middle East Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 286. Middle East Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 287. Middle East Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 288. Middle East Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 289. Africa Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 290. Africa Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 291. Africa Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 292. Africa Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 293. Africa Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 294. North America Molecular Imaging Device Sales, by Country K units (2018-2023)
  • Table 295. North America Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 296. North America Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 297. North America Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 298. North America Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 299. North America Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 300. United States Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 301. United States Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 302. United States Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 303. United States Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 304. United States Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 305. Canada Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 306. Canada Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 307. Canada Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 308. Canada Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 309. Canada Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 310. Mexico Molecular Imaging Device Sales, by Type K units (2018-2023)
  • Table 311. Mexico Molecular Imaging Device Sales, by Application K units (2018-2023)
  • Table 312. Mexico Molecular Imaging Device Sales, by Imaging technologies K units (2018-2023)
  • Table 313. Mexico Molecular Imaging Device Sales, by End users K units (2018-2023)
  • Table 314. Mexico Molecular Imaging Device Sales, by Molecular imaging agents K units (2018-2023)
  • Table 315. Molecular Imaging Device: by Type(USD/Units)
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Company Basic Information, Sales Area and Its Competitors
  • Table 325. Company Basic Information, Sales Area and Its Competitors
  • Table 326. Molecular Imaging Device: by Type(USD Million)
  • Table 327. Molecular Imaging Device Nuclear Medicine , by Region USD Million (2025-2030)
  • Table 328. Molecular Imaging Device PET/CT , by Region USD Million (2025-2030)
  • Table 329. Molecular Imaging Device PET Radiopharmacy , by Region USD Million (2025-2030)
  • Table 330. Molecular Imaging Device Other , by Region USD Million (2025-2030)
  • Table 331. Molecular Imaging Device: by Application(USD Million)
  • Table 332. Molecular Imaging Device Oncology , by Region USD Million (2025-2030)
  • Table 333. Molecular Imaging Device Cardio and vascular , by Region USD Million (2025-2030)
  • Table 334. Molecular Imaging Device Neurology , by Region USD Million (2025-2030)
  • Table 335. Molecular Imaging Device Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging) , by Region USD Million (2025-2030)
  • Table 336. Molecular Imaging Device: by Imaging technologies(USD Million)
  • Table 337. Molecular Imaging Device Gamma camera , by Region USD Million (2025-2030)
  • Table 338. Molecular Imaging Device Single-photon emission computed tomography (SPECT) , by Region USD Million (2025-2030)
  • Table 339. Molecular Imaging Device Molecular ultrasound imaging , by Region USD Million (2025-2030)
  • Table 340. Molecular Imaging Device Others , by Region USD Million (2025-2030)
  • Table 341. Molecular Imaging Device: by Molecular imaging agents(USD Million)
  • Table 342. Molecular Imaging Device Small molecules , by Region USD Million (2025-2030)
  • Table 343. Molecular Imaging Device Peptides , by Region USD Million (2025-2030)
  • Table 344. Molecular Imaging Device Engineered protein fragments , by Region USD Million (2025-2030)
  • Table 345. Molecular Imaging Device Aptamers , by Region USD Million (2025-2030)
  • Table 346. Molecular Imaging Device Nanoparticles , by Region USD Million (2025-2030)
  • Table 347. Molecular Imaging Device Others , by Region USD Million (2025-2030)
  • Table 348. South America Molecular Imaging Device, by Country USD Million (2025-2030)
  • Table 349. South America Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 350. South America Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 351. South America Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 352. South America Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 353. South America Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 354. Brazil Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 355. Brazil Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 356. Brazil Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 357. Brazil Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 358. Brazil Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 359. Argentina Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 360. Argentina Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 361. Argentina Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 362. Argentina Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 363. Argentina Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 364. Rest of South America Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 365. Rest of South America Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 366. Rest of South America Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 367. Rest of South America Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 368. Rest of South America Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 369. Asia Pacific Molecular Imaging Device, by Country USD Million (2025-2030)
  • Table 370. Asia Pacific Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 371. Asia Pacific Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 372. Asia Pacific Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 373. Asia Pacific Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 374. Asia Pacific Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 375. China Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 376. China Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 377. China Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 378. China Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 379. China Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 380. Japan Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 381. Japan Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 382. Japan Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 383. Japan Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 384. Japan Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 385. India Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 386. India Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 387. India Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 388. India Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 389. India Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 390. South Korea Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 391. South Korea Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 392. South Korea Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 393. South Korea Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 394. South Korea Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 395. Taiwan Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 396. Taiwan Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 397. Taiwan Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 398. Taiwan Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 399. Taiwan Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 400. Australia Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 401. Australia Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 402. Australia Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 403. Australia Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 404. Australia Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 405. Rest of Asia-Pacific Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 406. Rest of Asia-Pacific Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 407. Rest of Asia-Pacific Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 408. Rest of Asia-Pacific Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 409. Rest of Asia-Pacific Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 410. Europe Molecular Imaging Device, by Country USD Million (2025-2030)
  • Table 411. Europe Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 412. Europe Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 413. Europe Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 414. Europe Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 415. Europe Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 416. Germany Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 417. Germany Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 418. Germany Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 419. Germany Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 420. Germany Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 421. France Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 422. France Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 423. France Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 424. France Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 425. France Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 426. Italy Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 427. Italy Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 428. Italy Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 429. Italy Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 430. Italy Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 431. United Kingdom Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 432. United Kingdom Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 433. United Kingdom Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 434. United Kingdom Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 435. United Kingdom Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 436. Netherlands Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 437. Netherlands Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 438. Netherlands Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 439. Netherlands Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 440. Netherlands Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 441. Rest of Europe Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 442. Rest of Europe Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 443. Rest of Europe Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 444. Rest of Europe Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 445. Rest of Europe Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 446. MEA Molecular Imaging Device, by Country USD Million (2025-2030)
  • Table 447. MEA Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 448. MEA Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 449. MEA Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 450. MEA Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 451. MEA Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 452. Middle East Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 453. Middle East Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 454. Middle East Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 455. Middle East Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 456. Middle East Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 457. Africa Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 458. Africa Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 459. Africa Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 460. Africa Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 461. Africa Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 462. North America Molecular Imaging Device, by Country USD Million (2025-2030)
  • Table 463. North America Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 464. North America Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 465. North America Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 466. North America Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 467. North America Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 468. United States Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 469. United States Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 470. United States Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 471. United States Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 472. United States Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 473. Canada Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 474. Canada Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 475. Canada Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 476. Canada Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 477. Canada Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 478. Mexico Molecular Imaging Device, by Type USD Million (2025-2030)
  • Table 479. Mexico Molecular Imaging Device, by Application USD Million (2025-2030)
  • Table 480. Mexico Molecular Imaging Device, by Imaging technologies USD Million (2025-2030)
  • Table 481. Mexico Molecular Imaging Device, by End users USD Million (2025-2030)
  • Table 482. Mexico Molecular Imaging Device, by Molecular imaging agents USD Million (2025-2030)
  • Table 483. Molecular Imaging Device Sales: by Type(K units)
  • Table 484. Molecular Imaging Device Sales Nuclear Medicine , by Region K units (2025-2030)
  • Table 485. Molecular Imaging Device Sales PET/CT , by Region K units (2025-2030)
  • Table 486. Molecular Imaging Device Sales PET Radiopharmacy , by Region K units (2025-2030)
  • Table 487. Molecular Imaging Device Sales Other , by Region K units (2025-2030)
  • Table 488. Molecular Imaging Device Sales: by Application(K units)
  • Table 489. Molecular Imaging Device Sales Oncology , by Region K units (2025-2030)
  • Table 490. Molecular Imaging Device Sales Cardio and vascular , by Region K units (2025-2030)
  • Table 491. Molecular Imaging Device Sales Neurology , by Region K units (2025-2030)
  • Table 492. Molecular Imaging Device Sales Others (brain imaging, tumors, Alzheimer’s, aneurysms, bone scanning, irregular or inadequate functioning of organs, myocardial perfusion imaging) , by Region K units (2025-2030)
  • Table 493. Molecular Imaging Device Sales: by Imaging technologies(K units)
  • Table 494. Molecular Imaging Device Sales Gamma camera , by Region K units (2025-2030)
  • Table 495. Molecular Imaging Device Sales Single-photon emission computed tomography (SPECT) , by Region K units (2025-2030)
  • Table 496. Molecular Imaging Device Sales Molecular ultrasound imaging , by Region K units (2025-2030)
  • Table 497. Molecular Imaging Device Sales Others , by Region K units (2025-2030)
  • Table 498. Molecular Imaging Device Sales: by Molecular imaging agents(K units)
  • Table 499. Molecular Imaging Device Sales Small molecules , by Region K units (2025-2030)
  • Table 500. Molecular Imaging Device Sales Peptides , by Region K units (2025-2030)
  • Table 501. Molecular Imaging Device Sales Engineered protein fragments , by Region K units (2025-2030)
  • Table 502. Molecular Imaging Device Sales Aptamers , by Region K units (2025-2030)
  • Table 503. Molecular Imaging Device Sales Nanoparticles , by Region K units (2025-2030)
  • Table 504. Molecular Imaging Device Sales Others , by Region K units (2025-2030)
  • Table 505. South America Molecular Imaging Device Sales, by Country K units (2025-2030)
  • Table 506. South America Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 507. South America Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 508. South America Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 509. South America Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 510. South America Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 511. Brazil Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 512. Brazil Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 513. Brazil Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 514. Brazil Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 515. Brazil Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 516. Argentina Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 517. Argentina Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 518. Argentina Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 519. Argentina Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 520. Argentina Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 521. Rest of South America Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 522. Rest of South America Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 523. Rest of South America Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 524. Rest of South America Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 525. Rest of South America Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 526. Asia Pacific Molecular Imaging Device Sales, by Country K units (2025-2030)
  • Table 527. Asia Pacific Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 528. Asia Pacific Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 529. Asia Pacific Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 530. Asia Pacific Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 531. Asia Pacific Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 532. China Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 533. China Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 534. China Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 535. China Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 536. China Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 537. Japan Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 538. Japan Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 539. Japan Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 540. Japan Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 541. Japan Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 542. India Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 543. India Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 544. India Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 545. India Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 546. India Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 547. South Korea Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 548. South Korea Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 549. South Korea Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 550. South Korea Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 551. South Korea Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 552. Taiwan Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 553. Taiwan Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 554. Taiwan Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 555. Taiwan Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 556. Taiwan Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 557. Australia Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 558. Australia Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 559. Australia Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 560. Australia Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 561. Australia Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 562. Rest of Asia-Pacific Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 563. Rest of Asia-Pacific Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 564. Rest of Asia-Pacific Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 565. Rest of Asia-Pacific Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 566. Rest of Asia-Pacific Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 567. Europe Molecular Imaging Device Sales, by Country K units (2025-2030)
  • Table 568. Europe Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 569. Europe Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 570. Europe Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 571. Europe Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 572. Europe Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 573. Germany Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 574. Germany Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 575. Germany Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 576. Germany Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 577. Germany Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 578. France Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 579. France Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 580. France Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 581. France Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 582. France Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 583. Italy Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 584. Italy Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 585. Italy Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 586. Italy Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 587. Italy Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 588. United Kingdom Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 589. United Kingdom Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 590. United Kingdom Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 591. United Kingdom Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 592. United Kingdom Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 593. Netherlands Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 594. Netherlands Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 595. Netherlands Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 596. Netherlands Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 597. Netherlands Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 598. Rest of Europe Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 599. Rest of Europe Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 600. Rest of Europe Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 601. Rest of Europe Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 602. Rest of Europe Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 603. MEA Molecular Imaging Device Sales, by Country K units (2025-2030)
  • Table 604. MEA Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 605. MEA Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 606. MEA Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 607. MEA Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 608. MEA Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 609. Middle East Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 610. Middle East Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 611. Middle East Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 612. Middle East Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 613. Middle East Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 614. Africa Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 615. Africa Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 616. Africa Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 617. Africa Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 618. Africa Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 619. North America Molecular Imaging Device Sales, by Country K units (2025-2030)
  • Table 620. North America Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 621. North America Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 622. North America Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 623. North America Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 624. North America Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 625. United States Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 626. United States Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 627. United States Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 628. United States Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 629. United States Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 630. Canada Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 631. Canada Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 632. Canada Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 633. Canada Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 634. Canada Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 635. Mexico Molecular Imaging Device Sales, by Type K units (2025-2030)
  • Table 636. Mexico Molecular Imaging Device Sales, by Application K units (2025-2030)
  • Table 637. Mexico Molecular Imaging Device Sales, by Imaging technologies K units (2025-2030)
  • Table 638. Mexico Molecular Imaging Device Sales, by End users K units (2025-2030)
  • Table 639. Mexico Molecular Imaging Device Sales, by Molecular imaging agents K units (2025-2030)
  • Table 640. Molecular Imaging Device: by Type(USD/Units)
  • Table 641. Research Programs/Design for This Report
  • Table 642. Key Data Information from Secondary Sources
  • Table 643. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Imaging Device: by Type USD Million (2018-2023)
  • Figure 5. Global Molecular Imaging Device: by Application USD Million (2018-2023)
  • Figure 6. Global Molecular Imaging Device: by Imaging technologies USD Million (2018-2023)
  • Figure 7. Global Molecular Imaging Device: by Molecular imaging agents USD Million (2018-2023)
  • Figure 8. South America Molecular Imaging Device Share (%), by Country
  • Figure 9. Asia Pacific Molecular Imaging Device Share (%), by Country
  • Figure 10. Europe Molecular Imaging Device Share (%), by Country
  • Figure 11. MEA Molecular Imaging Device Share (%), by Country
  • Figure 12. North America Molecular Imaging Device Share (%), by Country
  • Figure 13. Global Molecular Imaging Device: by Type K units (2018-2023)
  • Figure 14. Global Molecular Imaging Device: by Application K units (2018-2023)
  • Figure 15. Global Molecular Imaging Device: by Imaging technologies K units (2018-2023)
  • Figure 16. Global Molecular Imaging Device: by Molecular imaging agents K units (2018-2023)
  • Figure 17. South America Molecular Imaging Device Share (%), by Country
  • Figure 18. Asia Pacific Molecular Imaging Device Share (%), by Country
  • Figure 19. Europe Molecular Imaging Device Share (%), by Country
  • Figure 20. MEA Molecular Imaging Device Share (%), by Country
  • Figure 21. North America Molecular Imaging Device Share (%), by Country
  • Figure 22. Global Molecular Imaging Device: by Type USD/Units (2018-2023)
  • Figure 23. Global Molecular Imaging Device share by Players 2023 (%)
  • Figure 24. Global Molecular Imaging Device share by Players (Top 3) 2023(%)
  • Figure 25. Global Molecular Imaging Device share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 29. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens Healthcare (Germany) Revenue: by Geography 2023
  • Figure 31. Philips Healthcare (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Philips Healthcare (Netherlands) Revenue: by Geography 2023
  • Figure 33. PerkinElmer (United States) Revenue, Net Income and Gross profit
  • Figure 34. PerkinElmer (United States) Revenue: by Geography 2023
  • Figure 35. Cyclopharma (France) Revenue, Net Income and Gross profit
  • Figure 36. Cyclopharma (France) Revenue: by Geography 2023
  • Figure 37. Hamamatsu Photonics (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Hamamatsu Photonics (Japan) Revenue: by Geography 2023
  • Figure 39. Scintomics (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Scintomics (Germany) Revenue: by Geography 2023
  • Figure 41. CardiArc Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 42. CardiArc Ltd. (United States) Revenue: by Geography 2023
  • Figure 43. Digirad Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 44. Digirad Corporation (United States) Revenue: by Geography 2023
  • Figure 45. Gamma Medica (United States) Revenue, Net Income and Gross profit
  • Figure 46. Gamma Medica (United States) Revenue: by Geography 2023
  • Figure 47. Global Molecular Imaging Device: by Type USD Million (2025-2030)
  • Figure 48. Global Molecular Imaging Device: by Application USD Million (2025-2030)
  • Figure 49. Global Molecular Imaging Device: by Imaging technologies USD Million (2025-2030)
  • Figure 50. Global Molecular Imaging Device: by Molecular imaging agents USD Million (2025-2030)
  • Figure 51. South America Molecular Imaging Device Share (%), by Country
  • Figure 52. Asia Pacific Molecular Imaging Device Share (%), by Country
  • Figure 53. Europe Molecular Imaging Device Share (%), by Country
  • Figure 54. MEA Molecular Imaging Device Share (%), by Country
  • Figure 55. North America Molecular Imaging Device Share (%), by Country
  • Figure 56. Global Molecular Imaging Device: by Type K units (2025-2030)
  • Figure 57. Global Molecular Imaging Device: by Application K units (2025-2030)
  • Figure 58. Global Molecular Imaging Device: by Imaging technologies K units (2025-2030)
  • Figure 59. Global Molecular Imaging Device: by Molecular imaging agents K units (2025-2030)
  • Figure 60. South America Molecular Imaging Device Share (%), by Country
  • Figure 61. Asia Pacific Molecular Imaging Device Share (%), by Country
  • Figure 62. Europe Molecular Imaging Device Share (%), by Country
  • Figure 63. MEA Molecular Imaging Device Share (%), by Country
  • Figure 64. North America Molecular Imaging Device Share (%), by Country
  • Figure 65. Global Molecular Imaging Device: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • GE Healthcare (United States)
  • Siemens Healthcare (Germany)
  • Philips Healthcare (Netherlands)
  • PerkinElmer (United States)
  • Cyclopharma (France)
  • Hamamatsu Photonics (Japan)
  • Scintomics (Germany)
  • CardiArc Ltd. (United States)
  • Digirad Corporation (United States)
  • Gamma Medica (United States)
Additional players considered in the study are as follows:
Gvi Medical Devices (United States) , Hitachi (Japan) , Mediso (Europe) , CMR Naviscan (United States) , NeuroLogica Corp (United States) , Toshiba (Japan) , Molecular Devices (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 227 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Imaging Device research Quantitative research analysis
Global Molecular Imaging Device research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as GE Healthcare (United States), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), PerkinElmer (United States), Cyclopharma (France), Hamamatsu Photonics (Japan), Scintomics (Germany), CardiArc Ltd. (United States), Digirad Corporation (United States) and Gamma Medica (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Adoption of Personalize Patient Care through these Devices " is seen as one of major influencing trends for Molecular Imaging Device Market during projected period 2023-2030.
The Molecular Imaging Device market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Molecular Imaging Device research Report?

Have a Query? Click Here

Other Related Reports

Fetal Doppler Comprehensive Study by Type (Hand-Held Dopplers, Desktop Dopplers), Application (Home Use, Hospital Use), Sales Channel (Over the Counter (OTC), Prescribed) Players and Region - Global ...
$ 3500
Closed System Drug Transfer Device Comprehensive Study by Type (Membrane-to-membrane Systems, Needleless Systems), Application (Hospitals & Clinics, Oncology Centers, Other End Users), Component Type...
$ 4000
Disposable Plastic Blood Bag Comprehensive Study by Type (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, Others), Application (Blood Banks, Hospitals, Clinics, Others)...
$ 3450
Tongue Depressors Comprehensive Study by Type (Reusable, Disposable), Distribution Channel (Online, Offline), Material Type (Wooden, Metal, Plastic), End-Use (Hospitals, Dental Clinics, Academic & Re...
$ 3350
Hearing Aids Comprehensive Study by Type (In the ear hearing aids (ITE), In the canal (ITC), Completely in the canal (CIC), Behind the ear (BTE), Receiver in canal (RIC)), Distribution Channel (Onlin...
$ 3650
UV Infection Control Device Comprehensive Study by Type (Mobile Type, Stationary Type, Others), Application (Immunodiagnostics, Molecular Diagnostics, Others), End Use (Hospitals, Medical Device Comp...
$ 3450